Difference between revisions of "Henry A. McKinnell, Jr."
| Line 1: | Line 1: | ||
| − | "Dr. Henry A. McKinnell Jr. became chief executive officer of Pfizer in January 2001 and chairman of the board in April 2001 after holding a series of senior executive positions spanning more than 32 years with the company. During his time at Pfizer, McKinnell helped turn the company from a leader in the pharmaceutical industry into a "transforming force" with the acquisitions of Warner-Lambert in 2000 and Pharmacia in 2003 and the subsequent successful integration of both firms, forming a behemoth that earned $45 billion in 2003. Observers described McKinnell as polished, stately, and avuncular, yet also exacting, passionate, and sometimes impatient." [http://www.referenceforbusiness.com/biography/M-R/McKinnell-Henry-A-Jr-1943.html] | + | "Dr. Henry A. McKinnell Jr. became chief executive officer of [[Pfizer]] in January 2001 and chairman of the board in April 2001 after holding a series of senior executive positions spanning more than 32 years with the company. During his time at Pfizer, McKinnell helped turn the company from a leader in the pharmaceutical industry into a "transforming force" with the acquisitions of Warner-Lambert in 2000 and Pharmacia in 2003 and the subsequent successful integration of both firms, forming a behemoth that earned $45 billion in 2003. Observers described McKinnell as polished, stately, and avuncular, yet also exacting, passionate, and sometimes impatient." [http://www.referenceforbusiness.com/biography/M-R/McKinnell-Henry-A-Jr-1943.html] |
He is also chairman of the Governance and Compensation Committee and is a member of the Audit Committee of the Board of Directors. [http://www.corporate-ir.net/ireye/ir_site.zhtml?ticker=mco&script=2220&item_id=46518] | He is also chairman of the Governance and Compensation Committee and is a member of the Audit Committee of the Board of Directors. [http://www.corporate-ir.net/ireye/ir_site.zhtml?ticker=mco&script=2220&item_id=46518] | ||
Since 2002, he is a member of the Board of Directors [http://www.exxonmobil.com/Corporate/InvestorInfo/Corp_II_Board.asp] of [[ExxonMobil]], the world's largest integrated oil company. See also [http://www.sourcewatch.org/index.php?title=ExxonMobil Sourcewatch on ExxonMobil] | Since 2002, he is a member of the Board of Directors [http://www.exxonmobil.com/Corporate/InvestorInfo/Corp_II_Board.asp] of [[ExxonMobil]], the world's largest integrated oil company. See also [http://www.sourcewatch.org/index.php?title=ExxonMobil Sourcewatch on ExxonMobil] | ||
| + | |||
| + | He is also Vice President of the [[International Federation of Pharmaceutical Manufacturers and Associations]]. | ||
== External links == | == External links == | ||
Revision as of 15:51, 25 April 2006
"Dr. Henry A. McKinnell Jr. became chief executive officer of Pfizer in January 2001 and chairman of the board in April 2001 after holding a series of senior executive positions spanning more than 32 years with the company. During his time at Pfizer, McKinnell helped turn the company from a leader in the pharmaceutical industry into a "transforming force" with the acquisitions of Warner-Lambert in 2000 and Pharmacia in 2003 and the subsequent successful integration of both firms, forming a behemoth that earned $45 billion in 2003. Observers described McKinnell as polished, stately, and avuncular, yet also exacting, passionate, and sometimes impatient." [1]
He is also chairman of the Governance and Compensation Committee and is a member of the Audit Committee of the Board of Directors. [2]
Since 2002, he is a member of the Board of Directors [3] of ExxonMobil, the world's largest integrated oil company. See also Sourcewatch on ExxonMobil
He is also Vice President of the International Federation of Pharmaceutical Manufacturers and Associations.
